The upcoming webinar is open to the public, and will share the latest developments in the battle against rare mtARS mitochondrial diseases.
CHOC conducts clinical trial for Glycogen Storage Disease type 1a
CHOC selected as West Coast site for gene therapy clinical trial for patients 8 years and older with Glycogen Storage Disease type 1a.
Common theme of hope resonates at inaugural CHOC/UCI Rare Disease Symposium and Family Conference
At the inaugural CHOC/UCI Rare Disease Conference, providers discussed plans for extended research, collaboration and treatment strategies.
Rare disease leaders to speak at inaugural symposium and family conference on March 11
The Inaugural CHOC and UCI Rare Disease Symposium & Family Conference will take place on Friday, March 11, 2022, from 10:30 a.m. to 3 p.m.
Neurologist awarded patent for novel technology to treat victims of brain injury and stroke
The patent for light-emitting nanoparticles will significantly advance CHOC’s research to develop non-invasive treatments for brain injuries.
CHOC joins select group of U.S. healthcare systems designated as a Rare Disease Center of Excellence
CHOC and UCI Health’s new designation is expected to attract more resources and recognition to help find novel cures for rare disorders.
